247 related articles for article (PubMed ID: 29116649)
1. WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway.
Hermann A; Wennmann DO; Gromnitza S; Edeling M; Van Marck V; Sudol M; Schaefer L; Duning K; Weide T; Pavenstädt H; Kremerskothen J
Hepatology; 2018 Apr; 67(4):1546-1559. PubMed ID: 29116649
[TBL] [Abstract][Full Text] [Related]
2. WWC Proteins: Important Regulators of Hippo Signaling in Cancer.
Höffken V; Hermann A; Pavenstädt H; Kremerskothen J
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467643
[TBL] [Abstract][Full Text] [Related]
3. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
4. The Hippo pathway component Wwc2 is a key regulator of embryonic development and angiogenesis in mice.
Hermann A; Wu G; Nedvetsky PI; Brücher VC; Egbring C; Bonse J; Höffken V; Wennmann DO; Marks M; Krahn MP; Schöler H; Heiduschka P; Pavenstädt H; Kremerskothen J
Cell Death Dis; 2021 Jan; 12(1):117. PubMed ID: 33483469
[TBL] [Abstract][Full Text] [Related]
5. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
[TBL] [Abstract][Full Text] [Related]
6. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.
Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096
[TBL] [Abstract][Full Text] [Related]
7. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
8. The Hippo signaling pathway in liver regeneration and tumorigenesis.
Hong L; Cai Y; Jiang M; Zhou D; Chen L
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
[TBL] [Abstract][Full Text] [Related]
9. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.
Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H
Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475
[TBL] [Abstract][Full Text] [Related]
10. An integrative pan-cancer analysis of WWC family genes and functional validation in lung cancer.
Huang H; Gu J; Kuang X; Yu Y; Rao B; Fang S; Lu J; Qiu F
Cell Signal; 2024 Mar; 115():111034. PubMed ID: 38190957
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary and molecular facts link the WWC protein family to Hippo signaling.
Wennmann DO; Schmitz J; Wehr MC; Krahn MP; Koschmal N; Gromnitza S; Schulze U; Weide T; Chekuri A; Skryabin BV; Gerke V; Pavenstädt H; Duning K; Kremerskothen J
Mol Biol Evol; 2014 Jul; 31(7):1710-23. PubMed ID: 24682284
[TBL] [Abstract][Full Text] [Related]
12. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
[TBL] [Abstract][Full Text] [Related]
13. Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer.
Jeong SH; Kim HB; Kim MC; Lee JM; Lee JH; Kim JH; Kim JW; Park WY; Kim SY; Kim JB; Kim H; Kim JM; Choi HS; Lim DS
J Clin Invest; 2018 Mar; 128(3):1010-1025. PubMed ID: 29400692
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of the mammalian Hippo signaling pathway.
Ji XY; Zhong G; Zhao B
Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
[TBL] [Abstract][Full Text] [Related]
15. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis.
Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E
J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.
Feng X; Lu T; Li J; Yang R; Hu L; Ye Y; Mao F; He L; Xu J; Wang Z; Liu Y; Zhang Y; Ji H; Zhao Y; Cheng S; Tian W; Zhang L
Hepatology; 2020 Jun; 71(6):1988-2004. PubMed ID: 31538665
[TBL] [Abstract][Full Text] [Related]
17. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.
Lee KP; Lee JH; Kim TS; Kim TH; Park HD; Byun JS; Kim MC; Jeong WI; Calvisi DF; Kim JM; Lim DS
Proc Natl Acad Sci U S A; 2010 May; 107(18):8248-53. PubMed ID: 20404163
[TBL] [Abstract][Full Text] [Related]
18. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D
Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of Hippo kinase signalling in human hepatic malignancies.
Li H; Wolfe A; Septer S; Edwards G; Zhong X; Abdulkarim AB; Ranganathan S; Apte U
Liver Int; 2012 Jan; 32(1):38-47. PubMed ID: 22098159
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
